Targeting of Cdc42-Interacting Protein 4-Calcineurin Signalosomes Improves Cardiac Structure and Function After...

Area of Science:

• Cardiovascular Research
• Molecular Cardiology
• Signal Transduction

Background:

• Calcineurin (CaN) has dual roles in cardiac remodeling and ischemia-reperfusion injury.
• CIP4/TRIP10 scaffold protein forms CaNAβ2 signaling compartments.
• CIP4-CaNAβ2 signalosomes drive pathological cardiac hypertrophy.

Purpose of the Study:

• Investigate the role of CIP4-CaNAβ2 signalosomes in ischemic heart disease.
• Determine if these signalosomes contribute to cardioprotection or adverse remodeling.
• Evaluate therapeutic potential of targeting CIP4-CaNAβ2 interactions.

Main Methods:

• Utilized CIP4 conditional knockout mice.
• Employed adeno-associated virus gene therapy in mice to inhibit CaNAβ2 or block CIP4-CaNAβ2 binding.
• Assessed outcomes following ischemia-reperfusion injury and myocardial infarction.

Main Results:

• CIP4 knockout and polyproline peptide treatment improved cardiac function and reduced infarct size post-myocardial infarction.
• CaNAβ2 depletion and VIVIT peptide worsened outcomes in myocardial infarction models.
• The polyproline peptide did not affect T-cell activation in vitro.

Conclusions:

• CIP4-CaNAβ2 signalosomes promote adverse cardiac remodeling and are not cardioprotective.
• Polyproline peptide gene therapy offers a potential treatment for ischemic cardiomyopathy.
• Targeting these complexes may benefit patients with ischemic cardiomyopathy and acute myocardial infarction.